Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis
- PMID: 16821081
- DOI: 10.1007/s10549-006-9296-7
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis
Abstract
Synucleins are emerging as central players in the fundamental neural processes and in the formation of pathologically insoluble deposits characteristic of neurodegenerative diseases. However, synuclein gamma (SNCG), previously identified as a breast cancer specific gene (BCSG1), is also highly expressed in breast carcinomas, but not expressed in normal or benign breast tissues. We analyzed SNCG gene expression in 93 clinical breast specimens and associated it with clinical outcome. Overall SNCG mRNA expression was detectable in 36% breast cancers. However, 81% of stage III/IV breast cancers were positive for SNCG expression, while only 15% of stage I/II breast cancers were positive for SNCG expression. In contrast, SNCG was undetectable in benign breast lesions. Expression of SNCG in the primary tumor also significantly associated with lymph node involvement and metastasis. There was no significant correlation between SNCG gene expression and age, menstruation, and status of ER, PR, PCNA, and HER-2. Patients whose tumors expressed SNCG had a significantly shorter DFS and a high probability of death when compared with those whose tumors did not express SNCG. The hazard ratio of metastasis or recurrence according to the SNCG status was 4.515 (95% CI, 1,188-17.154; P = 0.027). Cox multivariate analysis showed that SNCG had independent prognostic significance above and beyond conventional variables. This study suggests that the expression of SNCG is an independent predictive marker for recurrence and metastasis in breast cancer progression. SNCG is expected to be a useful marker for breast cancer progression and a potential target for breast cancer treatment.
Similar articles
-
Stage-specific expression of breast cancer-specific gene gamma-synuclein.Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):920-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504205
-
The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.Neuro Endocrinol Lett. 2006 Jun;27(3):381-6. Neuro Endocrinol Lett. 2006. PMID: 16816827
-
Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.Cancer Res. 2005 Sep 1;65(17):7635-43. doi: 10.1158/0008-5472.CAN-05-1089. Cancer Res. 2005. PMID: 16140929
-
The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.Clin Cancer Res. 2006 Aug 1;12(15):4474-80. doi: 10.1158/1078-0432.CCR-06-0074. Clin Cancer Res. 2006. PMID: 16899591 Review.
-
Human kallikrein 10, a predictive marker for breast cancer.Biol Chem. 2006 Jun;387(6):715-21. doi: 10.1515/BC.2006.090. Biol Chem. 2006. PMID: 16800732 Review.
Cited by
-
Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.Oncotarget. 2015 Sep 8;6(26):22553-63. doi: 10.18632/oncotarget.4155. Oncotarget. 2015. PMID: 26265438 Free PMC article.
-
Gamma synuclein promotes cancer metastasis through the MKK3/6-p38MAPK cascade.Int J Biol Sci. 2022 May 1;18(8):3167-3177. doi: 10.7150/ijbs.69155. eCollection 2022. Int J Biol Sci. 2022. PMID: 35637967 Free PMC article.
-
Amyloid-beta and tau protein beyond Alzheimer's disease.Neural Regen Res. 2024 Jun 1;19(6):1262-1276. doi: 10.4103/1673-5374.386406. Epub 2023 Oct 2. Neural Regen Res. 2024. PMID: 37905874 Free PMC article.
-
Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.Tumour Biol. 2014 Dec;35(12):11871-7. doi: 10.1007/s13277-014-2429-4. Epub 2014 Aug 21. Tumour Biol. 2014. PMID: 25142230
-
Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals.Diabetes. 2008 Sep;57(9):2438-44. doi: 10.2337/db08-0604. Epub 2008 Jun 20. Diabetes. 2008. PMID: 18567819 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous